Welcome to Johnson & Johnson Vision Care, Inc.

Welcome to
Johnson & Johnson Vision

We are committed to transforming the world’s vision, bringing healthy vision to everyone, everywhere, every day.

In 2017, Johnson & Johnson completed the acquisition of Abbott Medical Optics (AMO), adding ophthalmic products in three areas of patient care: cataract surgery, laser refractive surgery (LASIK) and consumer eye health. These products joined with the world-leading ACUVUE® Brand Contact Lens business, and formed our combined organization known as Johnson & Johnson Vision.

Johnson & Johnson Vision recently completed the acquisition of TearScience, Inc. – a medical device manufacturer dedicated to evaluating meibomian glands and treating Meibomian Gland Dysfunction, the leading cause of Dry Eye Disease – adding innovative solutions to our Dry Eye portfolio.

Johnson & Johnson Vision brings together insights, technology, and people to encourage professionals and patients to proactively preserve and enhance vision for a lifetime of overall well-being. We deliver meaningful innovation to improve patients’ sense of sight and enhance professionals’ abilities to deliver better outcomes. Learn about the steps we’re taking to advance eye health.